XNYS
FMC
Market cap1.12bUSD
Oct 09, Last price
8.35USD
1D
-1.87%
1Q
-18.24%
Jan 2017
-81.82%
Name
FMC Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The company is responsible for creating, commercializing, and selling various crop protection chemicals, including insecticides, herbicides, and fungicides, alongside biologicals, crop nutrition supplements, and seed treatment solutions. These innovations are employed in farming to boost harvest quantity and quality by mitigating diverse insect infestations, weed growth, and plant ailments. Furthermore, its solutions cater to non-agricultural sectors for general pest control. FMC distributes its comprehensive product range through its proprietary sales teams, in collaboration with alliance partners, and via independent distributors and sales representatives. Established in 1883, FMC Corporation is based in Philadelphia, Pennsylvania, and conducts operations across North America, Latin America, Europe, the Middle East, Africa, and Asia.
Related entities
Subsidiaries (12)
CHEMINOVA A/S
CHEMINOVA INDIA LIMITED
CHEMINOVA AGRO FRANCE
CHEMINOVA AGRO ITALIA S.R.L.
FMC AGRO BULGARIA EOOD
FMC AGRO LIMITED
FMC AGRO POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
FMC CHEMICALS LIMITED
FMC FINANCE B.V.
FMC INDIA PRIVATE LIMITED
FMC Netherlands Holdings II B.V.
FMC-AGRO HUNGARY KERESKEDELMI ÉS SZOLGÁLTATÓ KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG
Key people
Executive Chairman of the Board, Chief Executive Officer · since 2024
Ronaldo Pereira
President · since 2024
Andrew Sandifer
Chief Financial Officer, Executive Vice President · since 2018
Brian Angeli
Executive Vice President, Chief Marketing Officer · since 2024
Thaisa Hugenneyer
Executive Vice President - Integrated Supply Chain · since 2024
Executive Vice President, General Counsel, Corporate Secretary · since 2025
Jacqueline Scanlan
Chief Human Resources Officer, Executive Vice President · since 2023
Vsevolod Rostovtsev
Executive Vice President, Chief Technology Officer · since 2024
Nicholas Pfeiffer
Chief Accounting Officer, Vice President, Controller · since 2015
Steven Merkt
Director · since 2025
Eduardo Cordeiro
Independent Director · since 2011
Independent Director · since 2011
Independent Director · since 2020
Kathy Fortmann
Independent Director · since 2022
C. Scott Greer
Lead Independent Director · since 2022
K'lynne Johnson
Independent Director · since 2015
Independent Director · since 2009
Independent Director · since 2016
Independent Director · since 2008
John Raines
Independent Director · since 2024
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
2929 Walnut street
Philadelphia, PA 19104
US
Philadelphia, PA 19104
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||